Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Transplantation|August 16, 2019
mTOR Inhibitor Therapy Diminishes Circulating CD8+ CD28- Effector Memory T Cells and Improves Allograft Inflammation in Belatacept-refractory Renal Allograft RejectionCyd M Castro-Rojas, Alzbeta Godarova, Tiffany Shi, et al.
Plos Medicine|November 15, 2017
Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trialRita R Alloway, Alexander A Vinks, Tsuyoshi Fukuda, et al.
Clinical Transplantation|November 16, 2017
A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal diseaseBassam G Abu Jawdeh, Ervin Steve Woodle, Abbie D Leino, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 10, 2019
Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cellsE Steve Woodle, Simon Tremblay, Paul Brailey, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 5, 2023
Effects of invivo CXCR4 blockade and proteasome inhibition on bone marrow plasma cells in HLA-sensitized kidney transplant candidatesAmy P Rossi, Simon Tremblay, Cyd M Castro-Rojas, et al.
Transplantation Direct|December 20, 2016
Successful Simultaneous Liver-Kidney Transplantation in the Presence of Multiple High-Titered Class I and II Antidonor HLA AntibodiesFlavio Paterno, Alin Girnita, Paul Brailey, et al.
Transplantation|January 31, 2020
Reducing Donor-specific Antibody During Acute Rejection Diminishes Long-term Renal Allograft Loss: Comparison of Early and Late RejectionAlicia B Lichvar, Simon Tremblay, Abbie D Leino, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 2, 2019
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplantRobert R Redfield, Stanley C Jordan, Stephan Busque, et al.
JMIR Mental Health|July 11, 2025
Cognitive Remediation for Psychosis in Virtual Reality (ThinkTactic VR): Qualitative, Iterative, and User-Centered Codevelopment StudyJasmin Yee, Hannah Matheson, Bryce J M Bogie, et al.
Pageof 2